As the management of supraventricular tachycardia (SVT) evolves, advances in drug development, digital health technologies, and patient-centered care are reshaping the acute treatment pathway. This interactive
roundtable will explore how emerging therapies, innovative outpatient management strategies, and integration with wearable technologies may improve patient outcomes, optimize healthcare utilization, and redefine the transition from symptom relief to definitive arrhythmia care.
